Draft:Sim4Life: Difference between revisions
Content deleted Content added
Declining submission: adv - Submission reads like an advertisement (AFCH) |
- toned down language to make it sound (hopefully) less promotional |
||
| Line 24: | Line 24: | ||
| website = {{URL|https://zmt.swiss/sim4life/}} |
| website = {{URL|https://zmt.swiss/sim4life/}} |
||
}} |
}} |
||
[[File:S4l new head Wikipedia.png|thumb|'''Sim4Life promotional image''']] |
|||
| ⚫ | '''Sim4Life''' is a simulation platform developed by the Foundation for Research on Information Technologies in Society (IT'IS) with funding from Innosuisse<ref>{{Cite web |date=27 November 2014 |title=Development of a Multiphysics Simulation Platform for Computational BioMed and Life Sciences (Sim4Life) |url=https://www.aramis.admin.ch/Grunddaten/?ProjectID=28397 |access-date=17 March 2024 |website=ARAMIS}}</ref><ref>{{Cite web |date=1 June 2015 |title=R and D project : S4L-CAPITALIS - Extension of the Sim4Life Platform (S4L) for Analysis and Optimization of the Neurovascular and Neurological Devices and Treatments in the Head |url=https://www.aramis.admin.ch/Texte/?ProjectID=34223&Sprache=en-US |access-date=17 March 2024 |website=ARAMIS}}</ref>, formerly known as CTI, the Swiss federal innovation agency. The platform combines classical technical [[Computer-aided design|computer-aided-design]] tools with multi-physics solvers, [[computational human phantom|computational human phantoms]], [[Medical image computing|medical-image-based modeling]], and [[Tissue (biology)|physiological tissue]] models. Sim4Life – marketed by IT'IS partner ZMT Zurich MedTech AG (ZMT) – is used by [[Medical research|medical researchers]] to investigate, for example, [[personalized medicine]] and optimization of treatment modalities,<ref>{{Cite journal |date=7 February 2022 |title=Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis |url=https://www.nature.com/articles/s41591-021-01663-5 |journal=Nature Medicine |volume=28 |pages=260–271 |via=Nature}}</ref><ref>{{Cite journal |date=16 Mar 2022 |title=Experimental and computational evaluation of capacitive hyperthermia |url=https://www.tandfonline.com/doi/full/10.1080/02656736.2022.2048093 |journal=International Journal of Hyperthermia |volume=39 |issue=1 |pages=504–516 |via=Taylor & Francis Online}}</ref> safety aspects of [[magnetic resonance imaging]],<ref>{{Cite journal |date=2021 |title=An investigation into the minimum number of tissue groups required for 7T in-silico parallel transmit electromagnetic safety simulations in the human head |url=https://onlinelibrary.wiley.com/doi/full/10.1002/mrm.28467 |journal=Magnetic Resonance in Medicine |volume=85 |issue=2 |pages=1114–1122 |doi=10.1002/mrm.28467 |via=Wiley Online Library |last1=De Buck |first1=Matthijs H. S. |last2=Jezzard |first2=Peter |last3=Jeong |first3=Hongbae |last4=Hess |first4=Aaron T. |pmid=32845034 }}</ref><ref>{{Cite journal |date=13 January 2021 |title=Development, validation, and pilot MRI safety study of a high-resolution, open source, whole body pediatric numerical simulation model |journal=PLOS ONE |volume=16 |issue=1 |pages=e0241682 |pmc=7806143 |last1=Jeong |first1=H. |last2=Ntolkeras |first2=G. |last3=Alhilani |first3=M. |last4=Atefi |first4=S. R. |last5=Zöllei |first5=L. |last6=Fujimoto |first6=K. |last7=Pourvaziri |first7=A. |last8=Lev |first8=M. H. |last9=Grant |first9=P. E. |last10=Bonmassar |first10=G. |doi=10.1371/journal.pone.0241682 |pmid=33439896 |doi-access=free |bibcode=2021PLoSO..1641682J }}</ref><ref>{{Cite journal |date=2021 |title=Real-time assessment of potential peak local specific absorption rate value without phase monitoring: Trigonometric maximization method for worst-case local specific absorption rate determination |journal=Magnetic Resonance in Medicine |volume=85 |issue=6 |pages=3420–3433 |doi=10.1002/mrm.28635 |last1=Meliadò |first1=Ettore Flavio |last2=Sbrizzi |first2=Alessandro |last3=Van Den Berg |first3=Cornelis A. T. |last4=Luijten |first4=Peter R. |last5=Raaijmakers |first5=Alexander J. E. |pmid=33350525 |pmc=7986921 }}</ref> [[Non-invasive procedure|non-invasive]] methods of [[brain stimulation]],<ref>{{Cite journal |date=23 September 2022 |title=Modelling of magnetoelectric nanoparticles for non-invasive brain stimulation: a computational study |url=https://iopscience.iop.org/article/10.1088/1741-2552/ac9085/pdf |journal=Journal of Neural Engineering |volume=19 |pages=056020 |doi=10.1088/1741-2552/ac9085 |via=IOP Publishing |last1=Fiocchi |first1=Serena |last2=Chiaramello |first2=Emma |last3=Marrella |first3=Alessandra |last4=Bonato |first4=Marta |last5=Parazzini |first5=Marta |last6=Ravazzani |first6=Paolo |issue=5 |pmid=36075197 |bibcode=2022JNEng..19e6020F }}</ref><ref>{{Cite journal |date=2 February 2022 |title=Electroporation and cell killing by milli- to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation |journal=Scientific Reports |volume=12 |pages=1763 |doi=10.1038/s41598-022-04868-x |pmid=35110567 |bibcode=2022NatSR..12.1763G |last1=Gudvangen |first1=Emily |last2=Kim |first2=Vitalii |last3=Novickij |first3=Vitalij |last4=Battista |first4=Federico |last5=Pakhomov |first5=Andrei G. |issue=1 |pmc=8811018 }}</ref> and transcranial [[focused ultrasound]].<ref>{{Cite journal |date=February 3, 2022 |title=Comparison of Transcranial Focused Ultrasound and Transcranial Pulse Stimulation for Neuromodulation: A Computational Study |url=https://www.neuromodulationjournal.org/article/S1094-7159(21)06990-7/fulltext |journal=Neuromodulation: Technology at the Neural Interface |volume=25 |issue=4 |pages=606–613 |doi=10.1016/j.neurom.2021.12.012 |pmid=35125300 |via=Elsevier Inc. |last1=Truong |first1=D. Q. |last2=Thomas |first2=C. |last3=Hampstead |first3=B. M. |last4=Datta |first4=A. }}</ref><ref>{{Cite journal |date=August 2022 |title=Numerical investigation of the energy distribution of Low-intensity transcranial focused ultrasound neuromodulation for hippocampus |url=https://www.sciencedirect.com/science/article/abs/pii/S0041624X22000373 |journal=Ultrasonics |volume=124 |pages=106724 |doi=10.1016/j.ultras.2022.106724 |pmid=35299039 |via=Elsevier Science Direct |last1=Huang |first1=Y. |last2=Wen |first2=P. |last3=Song |first3=B. |last4=Li |first4=Y. |s2cid=247423819 }}</ref> |
||
| ⚫ | |||
| ⚫ | '''Sim4Life''' is a simulation platform developed by the Foundation for Research on Information Technologies in Society (IT'IS) with funding from Innosuisse<ref>{{Cite web |date=27 November 2014 |title=Development of a Multiphysics Simulation Platform for Computational BioMed and Life Sciences (Sim4Life) |url=https://www.aramis.admin.ch/Grunddaten/?ProjectID=28397 |access-date=17 March 2024 |website=ARAMIS}}</ref><ref>{{Cite web |date=1 June 2015 |title=R and D project : S4L-CAPITALIS - Extension of the Sim4Life Platform (S4L) for Analysis and Optimization of the Neurovascular and Neurological Devices and Treatments in the Head |url=https://www.aramis.admin.ch/Texte/?ProjectID=34223&Sprache=en-US |access-date=17 March 2024 |website=ARAMIS}}</ref>, formerly known as CTI, the Swiss federal innovation agency. The platform combines classical technical [[Computer-aided design|computer-aided-design]] tools with multi-physics solvers, [[computational human phantom|computational human phantoms]], [[Medical image computing|medical-image-based modeling]], and [[Tissue (biology)|physiological tissue]] models. Sim4Life – marketed by IT'IS partner ZMT Zurich MedTech AG (ZMT) – is used by [[Medical research|medical researchers]] to investigate, for example, [[personalized medicine]] |
||
| ⚫ | |||
{{Infobox Software |
{{Infobox Software |
||
| name = S4L<sup>lite</sup> |
| name = <em>S4L<sup>lite</sup></em> |
||
| logo = |
| logo = |
||
| developer = ZMT Zurich MedTech AG |
| developer = ZMT Zurich MedTech AG |
||
| Line 39: | Line 39: | ||
}} |
}} |
||
''S4L<sup>lite</sup>'', an online version of Sim4Life that is free-of-charge for students, was released in February 2023 |
''S4L<sup>lite</sup>'', an online version of Sim4Life that is free-of-charge for students, was released in February 2023 for team-learning and online collaboration on limited size projects with classmates and teachers. |
||
Both Sim4Life.web and ''S4L<sup>lite</sup>'' are |
Both Sim4Life.web and ''S4L<sup>lite</sup>'' are reliant on [[Open source|open-source]] o²S²PARC<ref>{{Cite journal |last1=Osanlouy |first1=Mahyar |last2=Bandrowski |first2=Anita |last3=De Bono |first3=Bernard |last4=Brooks |first4=David |last5=Cassarà |first5=Antonino M. |last6=Christie |first6=Richard |last7=Ebrahimi |first7=Nazanin |last8=Gillespie |first8=Tom |last9=Grethe |first9=Jeffrey S. |last10=Guercio |first10=Leonardo A. |last11=Heal |first11=Maci |last12=Lin |first12=Mabelle |last13=Kuster |first13=Niels |last14=Martone |first14=Maryann E. |last15=Neufeld |first15=Esra |date=24 June 2021 |title=The SPARC DRC: Building a Resource for the Autonomic Nervous System Community |journal=Frontiers in Physiology |volume=12 |pages=693735 |doi=10.3389/fphys.2021.693735 |pmc=8265045 |pmid=34248680 |doi-access=free |last16=Nickerson |first16=David P. |last17=Soltani |first17=Elias G. |last18=Tappan |first18=Susan |last19=Wagenaar |first19=Joost B. |last20=Zhuang |first20=Katie |last21=Hunter |first21=Peter J.}}</ref> technologies, which were developed as part of the 'Stimulating Peripheral Activity to Relieve Conditions' (SPARC)<ref>{{Cite web |date=15 February 2023 |title=The SPARC computational modeling platform o²S²PARC now powers ZMT's S4Llite |url=https://sparc.science/news-and-events/news/5U9a8F2TgWKDiFH6Cyw51i |access-date=17 March 2024 |website=SPARC — bridging the body and the brain}}</ref> program of the [[National Institutes of Health Common Fund]] to enable collaborative, reproducible, and sustainable [[Computational neuroscience|computational neurosciences]]. |
||
== References == |
== References == |
||
Revision as of 13:25, 28 March 2024
| Submission declined on 27 March 2024 by Devonian Wombat (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 17 March 2024 by Anuwrites (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Anuwrites 3 months ago.
| |
| Submission declined on 3 November 2023 by AirshipJungleman29 (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by AirshipJungleman29 8 months ago.
| |
Comment: Needs alot more sources that are reliable and independent to the subject. WP:COMPANY...Reada like an advertisement ANUwrites 23:01, 17 March 2024 (UTC)
- Comment: Does not appear that any of the sources provided contain significant coverage of the product, instead of trivial mentions as a tool used in research. ~~ AirshipJungleman29 (talk) 19:42, 3 November 2023 (UTC)
 | This article contains paid contributions. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. |
 | |
| Developer(s) | ZMT Zurich MedTech AG |
|---|---|
| Stable release | V8.0
/ March 14, 2024 |
| Type | Computer-aided design |
| Website | zmt |
Sim4Life is a simulation platform developed by the Foundation for Research on Information Technologies in Society (IT'IS) with funding from Innosuisse[1][2], formerly known as CTI, the Swiss federal innovation agency. The platform combines classical technical computer-aided-design tools with multi-physics solvers, computational human phantoms, medical-image-based modeling, and physiological tissue models. Sim4Life – marketed by IT'IS partner ZMT Zurich MedTech AG (ZMT) – is used by medical researchers to investigate, for example, personalized medicine and optimization of treatment modalities,[3][4] safety aspects of magnetic resonance imaging,[5][6][7] non-invasive methods of brain stimulation,[8][9] and transcranial focused ultrasound.[10][11]
Sim4Life V8.0, released in March 2024, is available as both a desktop version and as Sim4Life.web, an online version that runs in the cloud and can be used interchangeably with the desktop version.
| Developer(s) | ZMT Zurich MedTech AG |
|---|---|
| Type | Computer-aided design |
| Website | s4l-lite |
S4Llite, an online version of Sim4Life that is free-of-charge for students, was released in February 2023 for team-learning and online collaboration on limited size projects with classmates and teachers.
Both Sim4Life.web and S4Llite are reliant on open-source o²S²PARC[12] technologies, which were developed as part of the 'Stimulating Peripheral Activity to Relieve Conditions' (SPARC)[13] program of the National Institutes of Health Common Fund to enable collaborative, reproducible, and sustainable computational neurosciences.
References
- ^ "Development of a Multiphysics Simulation Platform for Computational BioMed and Life Sciences (Sim4Life)". ARAMIS. 27 November 2014. Retrieved 17 March 2024.
- ^ "R and D project : S4L-CAPITALIS - Extension of the Sim4Life Platform (S4L) for Analysis and Optimization of the Neurovascular and Neurological Devices and Treatments in the Head". ARAMIS. 1 June 2015. Retrieved 17 March 2024.
- ^ "Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis". Nature Medicine. 28: 260–271. 7 February 2022 – via Nature.
- ^ "Experimental and computational evaluation of capacitive hyperthermia". International Journal of Hyperthermia. 39 (1): 504–516. 16 Mar 2022 – via Taylor & Francis Online.
- ^ De Buck, Matthijs H. S.; Jezzard, Peter; Jeong, Hongbae; Hess, Aaron T. (2021). "An investigation into the minimum number of tissue groups required for 7T in-silico parallel transmit electromagnetic safety simulations in the human head". Magnetic Resonance in Medicine. 85 (2): 1114–1122. doi:10.1002/mrm.28467. PMID 32845034 – via Wiley Online Library.
- ^ Jeong, H.; Ntolkeras, G.; Alhilani, M.; Atefi, S. R.; Zöllei, L.; Fujimoto, K.; Pourvaziri, A.; Lev, M. H.; Grant, P. E.; Bonmassar, G. (13 January 2021). "Development, validation, and pilot MRI safety study of a high-resolution, open source, whole body pediatric numerical simulation model". PLOS ONE. 16 (1): e0241682. Bibcode:2021PLoSO..1641682J. doi:10.1371/journal.pone.0241682. PMC 7806143. PMID 33439896.
- ^ Meliadò, Ettore Flavio; Sbrizzi, Alessandro; Van Den Berg, Cornelis A. T.; Luijten, Peter R.; Raaijmakers, Alexander J. E. (2021). "Real-time assessment of potential peak local specific absorption rate value without phase monitoring: Trigonometric maximization method for worst-case local specific absorption rate determination". Magnetic Resonance in Medicine. 85 (6): 3420–3433. doi:10.1002/mrm.28635. PMC 7986921. PMID 33350525.
- ^ Fiocchi, Serena; Chiaramello, Emma; Marrella, Alessandra; Bonato, Marta; Parazzini, Marta; Ravazzani, Paolo (23 September 2022). "Modelling of magnetoelectric nanoparticles for non-invasive brain stimulation: a computational study". Journal of Neural Engineering. 19 (5): 056020. Bibcode:2022JNEng..19e6020F. doi:10.1088/1741-2552/ac9085. PMID 36075197 – via IOP Publishing.
- ^ Gudvangen, Emily; Kim, Vitalii; Novickij, Vitalij; Battista, Federico; Pakhomov, Andrei G. (2 February 2022). "Electroporation and cell killing by milli- to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation". Scientific Reports. 12 (1): 1763. Bibcode:2022NatSR..12.1763G. doi:10.1038/s41598-022-04868-x. PMC 8811018. PMID 35110567.
- ^ Truong, D. Q.; Thomas, C.; Hampstead, B. M.; Datta, A. (February 3, 2022). "Comparison of Transcranial Focused Ultrasound and Transcranial Pulse Stimulation for Neuromodulation: A Computational Study". Neuromodulation: Technology at the Neural Interface. 25 (4): 606–613. doi:10.1016/j.neurom.2021.12.012. PMID 35125300 – via Elsevier Inc.
- ^ Huang, Y.; Wen, P.; Song, B.; Li, Y. (August 2022). "Numerical investigation of the energy distribution of Low-intensity transcranial focused ultrasound neuromodulation for hippocampus". Ultrasonics. 124: 106724. doi:10.1016/j.ultras.2022.106724. PMID 35299039. S2CID 247423819 – via Elsevier Science Direct.
- ^ Osanlouy, Mahyar; Bandrowski, Anita; De Bono, Bernard; Brooks, David; Cassarà, Antonino M.; Christie, Richard; Ebrahimi, Nazanin; Gillespie, Tom; Grethe, Jeffrey S.; Guercio, Leonardo A.; Heal, Maci; Lin, Mabelle; Kuster, Niels; Martone, Maryann E.; Neufeld, Esra; Nickerson, David P.; Soltani, Elias G.; Tappan, Susan; Wagenaar, Joost B.; Zhuang, Katie; Hunter, Peter J. (24 June 2021). "The SPARC DRC: Building a Resource for the Autonomic Nervous System Community". Frontiers in Physiology. 12: 693735. doi:10.3389/fphys.2021.693735. PMC 8265045. PMID 34248680.
- ^ "The SPARC computational modeling platform o²S²PARC now powers ZMT's S4Llite". SPARC — bridging the body and the brain. 15 February 2023. Retrieved 17 March 2024.